Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Total Current Liabilities (2019 - 2025)

Historic Total Current Liabilities for Bolt Biotherapeutics (BOLT) over the last 7 years, with Q3 2025 value amounting to $10.0 million.

  • Bolt Biotherapeutics' Total Current Liabilities fell 4488.75% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year decrease of 4488.75%. This contributed to the annual value of $15.9 million for FY2024, which is 2248.73% down from last year.
  • Latest data reveals that Bolt Biotherapeutics reported Total Current Liabilities of $10.0 million as of Q3 2025, which was down 4488.75% from $12.3 million recorded in Q2 2025.
  • In the past 5 years, Bolt Biotherapeutics' Total Current Liabilities registered a high of $24.2 million during Q3 2022, and its lowest value of $10.0 million during Q3 2025.
  • Moreover, its 5-year median value for Total Current Liabilities was $18.1 million (2024), whereas its average is $17.8 million.
  • As far as peak fluctuations go, Bolt Biotherapeutics' Total Current Liabilities surged by 8934.66% in 2021, and later tumbled by 4488.75% in 2025.
  • Quarter analysis of 5 years shows Bolt Biotherapeutics' Total Current Liabilities stood at $21.3 million in 2021, then grew by 8.39% to $23.1 million in 2022, then dropped by 11.51% to $20.5 million in 2023, then fell by 22.49% to $15.9 million in 2024, then crashed by 37.15% to $10.0 million in 2025.
  • Its Total Current Liabilities stands at $10.0 million for Q3 2025, versus $12.3 million for Q2 2025 and $13.6 million for Q1 2025.